Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.87 | 1.87 | 0.00 |
Stocks | 98.13 | 98.13 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 26.56 | 23.66 |
Price to Book | 8.46 | 4.81 |
Price to Sales | 5.15 | 3.60 |
Price to Cash Flow | 19.77 | 16.59 |
Dividend Yield | 1.60 | 1.23 |
5 Years Earnings Growth | 11.28 | 12.42 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 27.14 | 14.57 |
Consumer Defensive | 25.56 | 6.44 |
Technology | 20.14 | 28.94 |
Communication Services | 11.84 | 9.02 |
Consumer Cyclical | 8.64 | 12.59 |
Financial Services | 4.49 | 14.09 |
Industrials | 2.18 | 11.92 |
Number of long holdings: 30
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 9.77 | 409.75 | -1.46% | |
Novo Nordisk B | DK0062498333 | 9.60 | 628.9 | -0.96% | |
Meta Platforms | US30303M1027 | 7.86 | 714.52 | +0.36% | |
L'Oreal | FR0000120321 | 5.96 | 340.60 | -3.54% | |
Stryker | US8636671013 | 5.40 | 391.40 | -1.18% | |
Philip Morris | US7181721090 | 4.55 | 144.41 | -0.63% | |
Visa A | US92826C8394 | 4.41 | 348.02 | +0.16% | |
IDEXX Labs | US45168D1046 | 3.94 | 459.78 | -0.17% | |
ADP | US0530151036 | 3.89 | 305.97 | -0.97% | |
Louis Vuitton | FR0000121014 | 3.87 | 684.20 | -1.82% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fundsmith Equity I Acc | 14.44B | 8.98 | 1.89 | 13.60 | ||
Fundsmith Equity I Inc | 4.23B | 9.17 | 1.95 | 13.62 | ||
Fundsmith Equity R Acc | 616.38M | 8.32 | 1.28 | 12.91 | ||
Fundsmith Equity R Inc | 16.4M | 8.32 | 1.28 | 12.90 | ||
Fundsmith Equity T Acc | 4.11B | 8.87 | 1.79 | 13.48 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review